Fast Market Research

Market Report, "mBio Diagnostics, Inc. - Product Pipeline Analysis, 2013 Update", Published

New Medical Devices market report from GlobalData: "mBio Diagnostics, Inc. - Product Pipeline Analysis, 2013 Update"

 
Repost This

Boston, MA -- (SBWIRE) -- 01/20/2014 -- MBio Diagnostics, Inc (MBio) is a medical diagnostic company. The company develops a suite of multiplexed diagnostic tests. Its products include MBio CD4 System and MBio Array System. The company's MBio CD4 System delivers absolute CD4 T helper cell counts at the point-of care in minutes. MBio's MBio Array System is a multiplexed fluorescence immunoassay system that provides the simultaneous and accurate measurement of multiple analytes from a single sample. Its products are developed for the rapid diagnosis of complex infectious diseases such as HIV and hepatitis. MBio is headquartered in Boulder, Colorado, the US.

This report is a source for data, analysis and actionable intelligence on the mBio Diagnostics, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

View Full Report Details and Table of Contents

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.<\li> - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.<\li> - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.<\li> - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.<\li> - Data on relevant clinical trials and product patent details, wherever applicable.<\li> - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get This Report

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.<\li> - Design and develop your product development, marketing and sales strategies.<\li> - Exploit M&A opportunities by identifying market players with the most innovative pipeline.<\li> -

Companies Mentioned in this Report: mBio Diagnostics, Inc.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- GenMark Diagnostics, Inc. (GNMK) - Product Pipeline Analysis, 2013 Update
- Siemens Healthcare Diagnostics Inc. - Product Pipeline Analysis, 2013 Update
- Chembio Diagnostics, Inc. (CEMI) - Product Pipeline Analysis, 2013 Update
- SQI Diagnostics Inc. (SQD) - Product Pipeline Analysis, 2013 Update
- Abbott Diagnostics - Product Pipeline Analysis, 2013 Update
- HTG Molecular Diagnostics, Inc. - Product Pipeline Analysis, 2013 Update
- Daan Diagnostics Ltd. - Product Pipeline Analysis, 2013 Update
- Roche Diagnostics Limited - Product Pipeline Analysis, 2013 Update
- True Diagnostics, Inc. - Product Pipeline Analysis, 2013 Update
- Savyon Diagnostics Ltd. - Product Pipeline Analysis, 2013 Update